Under a three-year contract won in open tender during the first quarter of CSC fiscal year 2013, CSC’s Healthcare Group will replace a Radius system for cellular pathology with its current laboratory solution. The agreement will immediately allow doctors to request cellular pathology tests and view all results online.
As an early adopter, Lewisham will also use current NextGen modules for cellular pathology and mortuary plus tools for vital cancer registry reporting.
The move supports calls for modern, efficient pathology services across the 450-bed University Hospital Lewisham and ten community health centres.
"Following this implementation we will be better placed to support the cellular pathology services now being offered across the trust in a more effective and efficient manner," said Alex Singer, Lewisham’s pathology manager. "CSC's laboratory solution is known for being robust and flexible. Having a solution that is reliable, easy to maintain and easy to customize was vital. It also allows us to develop and test new interfaces without impacting the core system or existing users and migrate gradually to CSC’s next-generation solution."
"Our NextGen solution is designed to meet demands on modern pathology services to do more for less and is another example of the work we are doing with our customers to develop solutions that meet their exact needs," said Andrea Fiumicelli, chief operating officer of CSC's Healthcare Group. "These and other innovations will help cement our position as the UK’s largest provider of laboratory information systems."
Lewisham Healthcare NHS Trust was formed in August 2010 after the merger of Lewisham Hospital NHS Trust and NHS Lewisham, and is one the first trusts to integrate acute and community services under one organisation.
Related news articles:
- CSC's Profile
CSC is a global leader in providing technology-enabled business solutions and services. Headquartered in Falls Church, Va., CSC has approximately 98,000 employees and reported revenue of $15.9 billion for the 12 months ended March 30, 2012.